Can a chest scan shortcut dangerous heart rhythm surgery?
NCT ID NCT07759427
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This trial tests whether a non-invasive mapping system called VIVO can help doctors locate the source of a dangerous heart rhythm called ventricular tachycardia (VT) before an invasive procedure. Patients with structural heart disease who need catheter ablation will be randomly assigned to receive either standard ablation or VIVO-guided ablation. The goal is to see if VIVO reduces procedure time and improves efficiency, while also assessing safety and patient outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VIVO-assisted mapping, a non-invasive cardiac mapping technology used to guide catheter ablation for ventricular tachycardia
- What this could lead to
- If successful, this approach could make VT ablation faster, safer, and more efficient, potentially improving outcomes for patients with structural heart disease.
- What could go wrong
- The trial is relatively small and early, and the benefit may not be confirmed. The procedure still involves invasive ablation, which carries risks like bleeding or heart damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATHETER ABLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Sussex County Hospital
NOT_YET_RECRUITINGBrighton, BN2 1ES, United Kingdom
-
The James Cook University Hospital
RECRUITINGMiddlesbrough, TS4 3B, United Kingdom
-
University Hospitals Coventry and Warwickshire
RECRUITINGCoventry, CV2 2DX, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Weight-Loss drug tirzepatide may help keep heart rhythm steady after ablation
- New heart ablation technique could tame dangerous rhythms in adults born with heart defects
- Heart device data may unlock secrets of rare heart muscle disease
- New ablation technique aims to zap heart flutter with less radiation and greater precision
- New catheter shows promise in heart ablation study
- 4,000 heart patients to be tracked after ablation procedure